← 產業報告目錄
Medical Probiotics Market Size, Share & Trends Analysis Report By Ingredient Type (Bacteria (Lactobacilli, Bifidobacterium, Streptococcus, and Bacillus), Yeast, Spore Formers, and Others), By Application (Probiotic Food & Beverages, Probiotic Dietary Supplements, Probiotics for Women’s Health, Infant Formula, and Others), By Distribution Channel, By Region, And By Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-17頁數 179報告編號 INSIGHTACE-e7a05f1864
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 39.32 Bn as of 2022, the global Medical Probiotics Market is forecasted to climb to USD 64.13 Bn by 2031, reflecting a compound annual growth rate of 5.76% over the 2023–2031 period.
Medical Probiotics encompasses "live microorganisms" that can improve health in various ways. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
The market's upward path is bolstered by rising healthcare spending, technological evolution, and the rising focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Medical Probiotics Market Snapshot
Chapter 4. Global Medical Probiotics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Ingredient Type Estimates & Trend Analysis
5.1. By Ingredient Type, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Ingredient Type:
5.2.1. Bacteria
5.2.1.1. Lactobacilli
5.2.1.2. Bifidobacterium
5.2.1.3. Streptococcus
5.2.1.4. Bacillus
5.2.2. Yeast
5.2.3. Spore Formers
5.2.4. Others
Chapter 6. Market Segmentation 2: By Distribution Channel Estimates & Trend Analysis
6.1. By Distribution Channel & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Distribution Channel:
6.2.1. Hypermarkets/Supermarkets
6.2.2. Pharmacies/Drugstores
6.2.3. Specialty Stores
6.2.4. Online Sales
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Application:
7.2.1. Probiotic Food & Beverages
7.2.1.1. Dairy Products
7.2.1.2. Non-dairy Beverages
7.2.1.3. Cereals
7.2.1.4. Baked Goods
7.2.1.5. Fermented Meat Products
7.2.2. Probiotic Dietary Supplements
7.2.3. Probiotics for Women's Health
7.2.4. Infant Formula
7.2.5. Others
Chapter 8. Medical Probiotics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts By Ingredient Type, 2019-2031
8.1.2. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2019-2031
8.1.3. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
8.1.4. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Medical Probiotics Market revenue (US$ Million) By Ingredient Type, 2019-2031
8.2.2. Europe Medical Probiotics Market revenue (US$ Million) By Distribution Channel, 2019-2031
8.2.3. Europe Medical Probiotics Market revenue (US$ Million) By Application, 2019-2031
8.2.4. Europe Medical Probiotics Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Medical Probiotics Market revenue (US$ Million) By Ingredient Type, 2019-2031
8.3.2. Asia Pacific Medical Probiotics Market revenue (US$ Million) By Distribution Channel, 2019-2031
8.3.3. Asia Pacific Medical Probiotics Market revenue (US$ Million) By Application, 2019-2031
8.3.4. Asia Pacific Medical Probiotics Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Medical Probiotics Market revenue (US$ Million) By Ingredient Type, (US$ Million) 2019-2031
8.4.2. Latin America Medical Probiotics Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
8.4.3. Latin America Medical Probiotics Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
8.4.4. Latin America Medical Probiotics Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Medical Probiotics Market revenue (US$ Million) By Ingredient Type, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Medical Probiotics Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Medical Probiotics Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Medical Probiotics Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Probi AB,
9.2.2. Abbott,
9.2.3. Lonza, Chr.
9.2.4. Hansen Holding A/S,
9.2.5. Danone S.A.,
9.2.6. Yakult Honsha Co., Ltd.,
9.2.7. Nestle S.A.,
9.2.8. DowDuPont Inc.,
9.2.9. Kerry Group plc.,
9.2.10. BioGaia AB, DSM,
9.2.11. Sun Genomics,
9.2.12. Evonik,
9.2.13. Probiotics International Limited (Protexin),
9.2.14. UAS Laboratories LLC,.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們